NYSE · Healthcare
FRANKLIN COVEY CO (FC)
As-reported financials and recent SEC filings for FRANKLIN COVEY CO, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$267.1M
Net income
$3.1M
Net margin
1.1%
Diluted EPS
$0.24
ROE
4.6%
P/E (TTM)
103.5×
Market cap
$280.0M
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $267.1M | $287.2M | $280.5M | $262.8M | $224.2M |
| Gross profit | $203.6M | $221.1M | $213.5M | $201.9M | $172.9M |
| Operating income | $5.7M | $33.0M | $26.4M | $23.7M | $8.1M |
| Net income | $3.1M | $23.4M | $17.8M | $18.4M | $13.6M |
| Diluted EPS | $0.24 | $1.74 | $1.24 | $1.27 | $0.96 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-17
View on EDGAR →42026-06-04
View on EDGAR →SCHEDULE 13G2026-05-15
View on EDGAR →SCHEDULE 13G2026-04-22
View on EDGAR →10-Q2026-04-08
View on EDGAR →42026-04-08
View on EDGAR →8-K2026-04-01
View on EDGAR →SCHEDULE 13G/A2026-03-26
View on EDGAR →Go deeper on FC
Search FRANKLIN COVEY CO’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.